I MAB (IMAB): IMAB 10Q due 4/3

Monksdream · 2024-04-01T18:24:01.1670000Z

IMAB 10Q due 4/3 https://investorshub.advfn.com/uimage/uploads/2024/4/1/hmbcnIMG_6932.gif

Play Episode

5min

Proactive - Interviews for investors

Cuscal FY25 update: profit grows on stable volumes

Cuscal Limited Managing Director Craig Kennedy talked with Proactive at AIM's Small and MIdcap conference about the company’s role in Australia's financial infrastructure and its recent financial performance for the first half of FY25. Kennedy explained that Cuscal is one of only five organisations in Australia with the full suite of licensing, infrastructure, and capabilities required to offer end-to-end payment services—alongside the four major banks. The company serves a range of clients including other banks, corporates, and fintechs, as well as working with NAB’s UBank division. Kennedy emphasised Cuscal’s position as a “neutral, independent” access point to payment infrastructure. On financial performance, Kennedy said Cuscal expects to “modestly exceed the forecast in the prospectus” issued at the time of its IPO in November. He noted that the business enjoys stable, predictable revenue and has completed significant investment in areas like real-time payments and operational upgrades. As a result, the company is beginning to see operational leverage. Kennedy stated: “Mid to high single digit volume growth will translate to low double digit profit growth.” He said H1 FY25 results showed 7% volume growth and between 12% to 13% profit growth. Reflecting on sector innovation, Kennedy described Cuscal as an "airport" enabling new players—like fintechs—to create and deliver new customer experiences on top of a stable infrastructure. He also said investors view the company as a “safe harbour,” appreciating its unique market position and stable growth outlook. #Cuscal #ASXStocks #FintechAustralia #PaymentsInfrastructure #CraigKennedy #InvestorUpdates #RealTimePayments #ASXConference #FinancialServices #BankingInnovation

Proactive - Interviews for investors

Candel Therapeutics shares positive survival data for investigational immunotherapy in NSCLC

Candel Therapeutics CEO Dr. Paul Peter Tak joined Steve Darling from Proactive to announce final survival data from a Phase 2a clinical trial evaluating the company’s investigational immunotherapy in patients with stage III/IV non-small cell lung cancer (NSCLC) who had an inadequate response to immune checkpoint inhibitor (ICI) treatment. The study reported a median overall survival (mOS) of 24.5 months in 46 evaluable patients who received two courses of the investigational therapy. In a subset of patients who had progressive disease at baseline despite ICI treatment, mOS was 21.5 months. Historically, similar patients receiving standard-of-care chemotherapy have had mOS between 9.8 and 11.8 months, with published studies rarely exceeding 12 months. With a median follow-up of 32.4 months, the data demonstrated long-term survival benefits, with 37% of patients who had progressive disease despite ICI therapy still alive two years after treatment. Based on these positive results, Candel Therapeutics will continue advancing the development program, including preparations for a potential registrational trial in patients with non-squamous histology NSCLC. The U.S. Food and Drug Administration (FDA) has previously granted Fast Track Designation for the investigational therapy in combination with an antiviral agent and ICI therapy for patients with stage III/IV NSCLC who are resistant to first-line PD-(L)1 inhibitors and do not have activating molecular driver mutations or have progressed on targeted therapy. These findings support the therapy’s potential as a new treatment option for NSCLC patients with limited alternatives. #proactiveinvestors #candeltherapeuticsinc #nasdaq #cadl #CancerTreatment #ViralTherapy #ProstateCancer #PancreaticCancer #Glioblastoma #PaulPeterTak #ClinicalTrials #BiotechNews #Immunotherapy #Oncology #CancerResearch

Proactive - Interviews for investors

Airtasker CEO on growth, AI & global expansion

Airtasker Ltd CEO Tim Fung talked with Proactive at AIM's Small and Midcap Conference about the company’s strategic focus across innovation, growth, and international expansion.** Fung outlined how Airtasker differentiates itself in the local services marketplace by operating as a community platform, where both customers and taskers set job scopes and pricing, rather than the company enforcing set rates. He emphasised Airtasker’s approach to worker empowerment, noting, *“The top people on our platform are running 150, 200 thousand dollars a year doing these kinds of jobs.”* Fung also acknowledged the challenges of the current consumer environment, pointing to Airtasker’s 14.8% revenue growth in the half as a result of lean operations and renewed brand investment. A key part of Airtasker’s strategy involves innovation across customer acquisition, user experience, and operational efficiency—highlighting its collaboration with OpenAI and use of AI tools like Copilot and Zendesk AI. Fung also discussed partnerships, including one with Visa Cash App Racing Bulls, as examples of how Airtasker showcases the diverse range of skilled work enabled by the platform. He concluded by outlining the investor case: a cash-generative, proven business model in Australia being used to fund international growth in the US and UK, offering upside potential with limited downside. #Airtasker #TimFung #ASX #GigEconomy #AIIntegration #MarketplacePlatform #SmallCapStocks #TechInnovation #FY25Strategy #ProactiveInvestors #OpenAI #GlobalExpansion #InvestorUpdates #StartupGrowth

Proactive - Interviews for investors

MP Evans posts record 2024 results, eyes growth

MP Evans Group PLC (AIM:MPE) CEO Matthew Coulson takes Proactive's Stephen Gunnion through the company’s record results for 2024 and the strong start to 2025. MP Evans Group reported a robust financial performance in 2024, with Coulson confirming a record profit and a 66% increase in earnings per share. “It’s been a fantastic year for the group,” Coulson said, noting that high pricing supported the result, with prices averaging around $820 per tonne for the year. The company processed 1.6 million tonnes of crop in 2024, maintaining output despite weather-related challenges in Indonesia. Coulson highlighted this achievement in context: while Indonesia saw a slight national decline in crop yield, MP Evans sustained high volumes, reflecting operational resilience. Planting activity also continued across its operations, particularly in South Sumatra and East Kalimantan. The company expects to exceed 11,000 hectares planted at its Musi Rawas estate in early 2025, while its ABK site in East Kalimantan is set for more extensive development this year. Coulson also noted a milestone in sustainability, with over 250,000 tonnes of certified sustainable output processed across the company’s six mills in 2024. Looking ahead, he said 2025 had started positively, with pricing in the first two months averaging $870 per tonne, and the company is actively exploring acquisition opportunities. Visit Proactive’s YouTube channel for more insightful interviews. Don’t forget to like this video, subscribe to the channel, and enable notifications so you never miss an update. #MPEvans #PalmOil #Agribusiness #SustainableFarming #IndonesiaAgriculture #CropProduction #AgricultureInvestment #ESGInvesting #DividendStocks #CommoditiesMarket #ProactiveInvestors

Followers	290
Posts	59723
Boards Moderated	3
Alias Born	08/29/2007

Volume:	157,775
Day Range:	0.81 - 0.86
Bid:	0.8103
Ask:	0.859
Last Trade Time:	5:41:01 PM EDT
Total Trades:	514

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

IMAB Detailed Quote

Recent IMAB News

More IMAB News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent IMAB News

Go Ad-Free